1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Biomarkers Market
2.3. Global Biomarkers Market, By Product, 2025 (US$ Million)
2.4. Global Biomarkers Market, By Type, 2025 (US$ Million)
2.5. Global Biomarkers Market, By Application, 2025 (US$ Million)
2.6. Global Biomarkers Market, By Disease Indication, 2025 (US$ Million)
2.7. Global Biomarkers Market, By Geography, 2025 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2025
3. Biomarkers Market: Competitive Analysis
3.1. Market Positioning of Key Biomarkers Market Vendors
3.2. Strategies Adopted by Biomarkers Market Vendors
4. Biomarkers Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Biomarkers Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Biomarkers Market: By Product, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Consumables
5.3.2. Services
5.3.3. Software
6. Biomarkers Market: By Type, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Safety Biomarkers
6.3.2. Efficacy Biomarkers
6.3.3. Predictive Biomarkers
6.3.4. Surrogate Biomarkers
6.3.5. Pharmacodynamics Biomarkers
6.3.6. Prognostic Biomarkers
6.3.7. Validation Biomarkers
7. Biomarkers Market: By Application, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Diagnostics
7.3.2. Drug Discovery & Development
7.3.3. Personalized Medicine
7.3.4. Disease Risk Assessment
7.3.5. Other Applications
8. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Cancer
8.3.2. Infectious Diseases
8.3.3. Immune Disorders
8.3.4. Neurological Disorders
8.3.5. Cardiovascular Disorders
8.3.6. Other Disease Indications
9. North America Biomarkers Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Biomarkers Market: By Product, 2024-2034, USD (Million)
9.3. Biomarkers Market: By Type, 2024-2034, USD (Million)
9.4. Biomarkers Market: By Application, 2024-2034, USD (Million)
9.5. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
9.6. Biomarkers Market: By Region, 2024-2034, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
9.6.1.1.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
9.6.1.1.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
9.6.1.1.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
9.6.1.2.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
9.6.1.2.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
9.6.1.2.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
9.6.1.3.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
9.6.1.3.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
9.6.1.3.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10. UK and European Union Biomarkers Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.3. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.4. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.5. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10.6. Biomarkers Market: By Region, 2024-2034, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.6.1.1.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.6.1.1.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6.1.1.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.6.1.2.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.6.1.2.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6.1.2.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.6.1.3.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.6.1.3.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6.1.3.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.6.1.4.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.6.1.4.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6.1.4.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10.6.1.5. France
10.6.1.5.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.6.1.5.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.6.1.5.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6.1.5.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
10.6.1.6.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
10.6.1.6.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6.1.6.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11. Asia Pacific Biomarkers Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.3. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.4. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.5. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11.6. Biomarkers Market: By Region, 2024-2034, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.6.1.1.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.6.1.1.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6.1.1.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.6.1.2.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.6.1.2.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6.1.2.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11.6.1.3. India
11.6.1.3.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.6.1.3.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.6.1.3.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6.1.3.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.6.1.4.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.6.1.4.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6.1.4.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.6.1.5.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.6.1.5.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6.1.5.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
11.6.1.6.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
11.6.1.6.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6.1.6.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
12. Latin America Biomarkers Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Biomarkers Market: By Product, 2024-2034, USD (Million)
12.3. Biomarkers Market: By Type, 2024-2034, USD (Million)
12.4. Biomarkers Market: By Application, 2024-2034, USD (Million)
12.5. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
12.6. Biomarkers Market: By Region, 2024-2034, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
12.6.1.1.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
12.6.1.1.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
12.6.1.1.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
12.6.1.2.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
12.6.1.2.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
12.6.1.2.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
12.6.1.3.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
12.6.1.3.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
12.6.1.3.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
13. Middle East and Africa Biomarkers Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. Biomarkers Market: By Product, 2024-2034, USD (Million)
13.3. Biomarkers Market: By Type, 2024-2034, USD (Million)
13.4. Biomarkers Market: By Application, 2024-2034, USD (Million)
13.5. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
13.6. Biomarkers Market: By Region, 2024-2034, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
13.6.1.1.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
13.6.1.1.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
13.6.1.1.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
13.6.1.2.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
13.6.1.2.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
13.6.1.2.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Biomarkers Market: By Product, 2024-2034, USD (Million)
13.6.1.3.2. Biomarkers Market: By Type, 2024-2034, USD (Million)
13.6.1.3.3. Biomarkers Market: By Application, 2024-2034, USD (Million)
13.6.1.3.4. Biomarkers Market: By Disease Indication, 2024-2034, USD (Million)
14. Company Profile
14.1. F. Hoffmann-La Roche Ltd. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. Thermo Fisher Scientific Inc.
14.3. Abbott Laboratories
14.4. QIAGEN N.V.
14.5. PerkinElmer, Inc.
14.6. Merck KGaA
14.7. Bio-Rad Laboratories, Inc.
14.8. Enzo Biochem, Inc.
14.9. Charles River Laboratories International, Inc.
14.10. Eurofins Scientific
14.11. Other Notable Players
